Suven Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2026 ,inter alia, to consider and approve Audited Financial Results ....
SUVEN · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Suven Life Sciences Limited has issued a routine board meeting intimation under SEBI LODR Regulation 29. The meeting is scheduled for 13th May 2026 to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and financial year ended 31st March 2026. The company has also informed that the Trading Window for insiders was closed from 1st April 2026 and will remain closed until 48 hours after the results are declared, i.e., 15th May 2026. This is a standard pre-results disclosure filing.
This is routine regulatory compliance. Shareholders can expect audited FY2026 results to be declared shortly after the board meeting. The closed trading window indicates results are imminent.